Aerie Pharmaceuticals, Inc. Reports Third Quarter 2014 Financial Results And Provides Business And Product Development Update

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today reported financial results for third quarter 2014 and provided an update on the Company’s business highlights.

Help employers find you! Check out all the jobs and post your resume.